Nuvectis Pharma, Inc. (NVCT)
NASDAQ: NVCT · Real-Time Price · USD
8.39
-0.61 (-6.73%)
At close: May 12, 2025, 4:00 PM
8.40
+0.02 (0.18%)
After-hours: May 12, 2025, 6:52 PM EDT
Nuvectis Pharma Employees
Nuvectis Pharma had 13 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
13
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,550,846
Market Cap
198.18M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 13 | 0 | - |
| Dec 31, 2023 | 13 | 2 | 18.18% |
| Dec 31, 2022 | 11 | 3 | 37.50% |
| Dec 31, 2021 | 8 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
NVCT News
- 6 days ago - Nuvectis Pharma, Inc. Reports First Quarter 2025 Financial Results and Business Highlights - GlobeNewsWire
- 13 days ago - Nuvectis Pharma Provides Poster Presentation Highlights for NXP900 from the 2025 AACR Meeting - GlobeNewsWire
- 2 months ago - Nuvectis Pharma to Participate in the 37th Annual Roth Conference - GlobeNewsWire
- 3 months ago - Nuvectis Pharma Announces Closing of $15.5 Million Public Offering of Common Stock and Full Exercise of Underwriter's Over-Allotment Option - GlobeNewsWire
- 3 months ago - Nuvectis: Additional Data In Q2 Of 2025 Could Allow It To Stage A Comeback - Seeking Alpha
- 3 months ago - Nuvectis Pharma Announces Pricing of $13.5 Million Public Offering of Common Stock - GlobeNewsWire
- 3 months ago - Nuvectis Pharma Announces Proposed Public Offering of Common Stock - GlobeNewsWire
- 6 months ago - Nuvectis Pharma CEO Says Increased Dose Intensity Needed To Drive More Efficacy From Ovarian Cancer Lead Drug - Benzinga